Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

N-acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances.

European journal of clinical pharmacology - 1 Jan 1997

Gawrońska-Szklarz B, Górnik W, Pawlik A, Kunicki P, Wójcicki J, Sitkiewicz D, Sych Z

Abstract excerpt

The N-acetylation and hydroxylation (CYP2D6) genetic polymorphisms were assessed in 43 healthy subjects and in 84 type II (non-insulin-dependent) diabetics. The proportions of slow and fast acetylators as well as poor and extensive metabolisers in a group of diabetics suffering from microvascular disturbances (nephropathy, retinopathy and neuropathy) were compared with the control group and with diabetics without...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylation
Share to Aged
Share to Debrisoquin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Gene Frequency

Share to Hydroxylation

Share to Phenotype

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 9112055
DOI: 10.1007/s002280050226

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

N-acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances.PMID 9112055Read ↗

[PHENOTYPIC POLYMORPHISM OF N-ACETYLTRANSFERASE 2 IN PATIENTS WITH DIABETES MELLITUS].Semantic proximity Read ↗

Acetylator phenotypes in diabetes mellitus.Semantic proximity Read ↗

N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus.Semantic proximity Read ↗

Dapsone N-acetylation, metoprolol alpha-hydroxylation, and S-mephenytoin 4-hydroxylation polymorphisms in an Indonesian population: a cocktail and extended phenotyping assessment trial.Semantic proximity Read ↗

Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation CapacitySemantic proximity Read ↗

Debrisoquine hydroxylation and sulfamethazine acetylation in a Chinese population.Semantic proximity Read ↗

N-acetylation phenotyping using dapsone in a Jordanian population.Semantic proximity Read ↗

N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndrome.Semantic proximity Read ↗

Acetylator phenotypes of Jordanian diabetics.Semantic proximity Read ↗

The acetylation and oxidation phenotypes in insulin-dependent diabetes mellitus.Semantic proximity Read ↗

N-acetylation phenotyping with sulfamethazine in an Iranian population.Semantic proximity Read ↗

N-acetylation phenotyping with sulphadimidine in a Turkish population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.